当前位置: X-MOL 学术Clin. Oral Investig. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Long-term effects of splint therapy in patients with posttraumatic stress disease (PTSD).
Clinical Oral Investigations ( IF 3.4 ) Pub Date : 2020-01-16 , DOI: 10.1007/s00784-019-03184-5
A Wolowski 1 , T Eger 2 , R Braas 3 , J Gohr 2 , N Weber 1 , K Witanski 1 , F Wörner 2
Affiliation  

OBJECTIVES The aim of a pilot study was to clarify the question of whether mouth opening restrictions in patients with PTSD by means of splint therapy (st) show long-term therapeutic effects in the case of functional disorders. MATERIAL AND METHODS In 31 of 36 inpatients (soldiers, average age 37.1 ± 7.3 years, 26.7 ± 2.1 teeth) with confirmed posttraumatic stress disorder, chronic pain intensity > 6 (visual analogue scale 0 to 10), the mouth opening was determined, and the functional status (RDC-TMD) was recorded. All participants received a splint that was worn at night. A control of the therapeutic effect of the splint occurred after 6 weeks, 3, 6, and 12 months. RESULTS The mouth opening initially had an average of 30.9 ± 6.5 mm (median 31 mm). The pain intensity (PI) was reported to be on average VAS 8.3 ± 0.9, the chronic degree of pain according to von Korff was 3.9 ± 03. Six weeks after the st (n = 31), the average mouth opening was 49.5 ± 6.3 mm (median 51.5). PI was given as VAS 2.3 ± 1.1 on average. After 3, 6, and 12 months, 24, 15, and 14 subjects could be interviewed regarding PI. Based on the last examination date of all subjects, the average PI was given as 1.1 ± 0.9 (median 1). CONCLUSION The presented data show that the therapeutic short-term results achieved by means of a splint remain valid on the long term despite continued PTSD. CLINICAL RELEVANCE The presented study shows that patients will benefit in the long term from a splint and remain symptom-free, even if this mental illness persists.

中文翻译:

夹板治疗对创伤后应激障碍(PTSD)患者的长期影响。

目的一项初步研究的目的是阐明通过夹板疗法(st)对PTSD患者的张口限制是否在功能障碍的情况下显示出长期治疗效果的问题。材料和方法在确诊的创伤后应激障碍,慢性疼痛强度> 6(视觉模拟量表0至10)的36位住院患者(士兵,平均年龄37.1±7.3岁,26.7±2.1牙齿)中,有31位被确定为张口,并且记录功能状态(RDC-TMD)。所有参与者都收到了晚上佩戴的夹板。在6周,3、6和12个月后进行夹板治疗效果的控制。结果最初的张口平均为30.9±6.5毫米(中值31毫米)。据报告,疼痛强度(PI)平均为VAS 8.3±0.9,根据冯·科夫(von Korff)的慢性疼痛程度为3.9±03。在st(n = 31)六周后,平均张口为49.5±6.3 mm(中值51.5)。PI的平均值为VAS 2.3±1.1。在3、6和12个月后,可以就PI采访24、15和14位受试者。根据所有受试者的最后检查日期,平均PI为1.1±0.9(中位数1)。结论所提供的数据表明,尽管创伤后应激障碍持续存在,但通过夹板获得的短期治疗效果仍长期有效。临床相关性这项研究表明,即使这种精神疾病持续存在,患者也将从中长期受益于夹板并且保持无症状。PI的平均值为VAS 2.3±1.1。在3、6和12个月后,可以就PI采访24、15和14位受试者。根据所有受试者的最后检查日期,平均PI为1.1±0.9(中位数1)。结论所提供的数据表明,尽管创伤后应激障碍持续存在,但通过夹板获得的短期治疗效果仍长期有效。临床相关性这项研究表明,即使这种精神疾病持续存在,患者也将从中长期受益于夹板并且保持无症状。PI的平均值为VAS 2.3±1.1。在3、6和12个月后,可以就PI采访24、15和14位受试者。根据所有受试者的最后检查日期,平均PI为1.1±0.9(中位数1)。结论所提供的数据表明,尽管创伤后应激障碍持续存在,但通过夹板获得的短期治疗效果仍长期有效。临床相关性这项研究表明,即使这种精神疾病持续存在,患者也将从中长期受益于夹板并且保持无症状。结论所提供的数据表明,尽管创伤后应激障碍持续存在,但通过夹板获得的短期治疗效果仍长期有效。临床相关性这项研究表明,即使这种精神疾病持续存在,患者也将从中长期受益于夹板并且保持无症状。结论所提供的数据表明,尽管创伤后应激障碍持续存在,但通过夹板获得的短期治疗效果仍长期有效。临床相关性这项研究表明,即使这种精神疾病持续存在,患者也将从中长期受益于夹板并且保持无症状。
更新日期:2020-01-17
down
wechat
bug